Literature DB >> 16636830

Therapeutic effect of llama derived VHH fragments against Streptococcus mutans on the development of dental caries.

Carina Krüger1, Anna Hultberg, Harold Marcotte, Pim Hermans, Sandra Bezemer, Leon G J Frenken, Lennart Hammarström.   

Abstract

Streptococcus mutans is the main cause of dental caries. We evaluated the therapeutic effect of variable regions of a llama heavy chain antibody fragments directed against S. mutans named S36-VHH (S for Streptococcus) alone or fused with glucose oxidase (GOx) from Aspergillus niger. Western blot analysis and ELISA revealed binding of the S36-VHH to the streptococcal antigen I/II adhesin molecule of S. mutans serotype C. In a rat-desalivated caries model, daily administration of S36-VHH significantly reduced the development of smooth surface caries. No additional therapeutic effect of GOx was observed. Our results suggest that llama VHH antibodies may be a potential benefit as prophylaxis against dental caries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636830     DOI: 10.1007/s00253-006-0347-0

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  8 in total

1.  Integrative expression system for delivery of antibody fragments by lactobacilli.

Authors:  M Cruz Martín; Neha Pant; Victor Ladero; Gökçe Günaydin; Kasper Krogh Andersen; Beatriz Alvarez; Noelia Martínez; Miguel A Alvarez; Lennart Hammarström; Harold Marcotte
Journal:  Appl Environ Microbiol       Date:  2011-01-21       Impact factor: 4.792

Review 2.  Biotechnological applications of recombinant single-domain antibody fragments.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2011-06-09       Impact factor: 5.328

3.  Engineered single-domain antibodies with high protease resistance and thermal stability.

Authors:  Greg Hussack; Tomoko Hirama; Wen Ding; Roger Mackenzie; Jamshid Tanha
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

Review 4.  Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications.

Authors:  Yongzhong Wang; Zhen Fan; Lei Shao; Xiaowei Kong; Xianjuan Hou; Dongrui Tian; Ying Sun; Yazhong Xiao; Li Yu
Journal:  Int J Nanomedicine       Date:  2016-07-21

5.  Joining the in vitro immunization of alpaca lymphocytes and phage display: rapid and cost effective pipeline for sdAb synthesis.

Authors:  Lubos Comor; Saskia Dolinska; Katarina Bhide; Lucia Pulzova; Irene Jiménez-Munguía; Elena Bencurova; Zuzana Flachbartova; Lenka Potocnakova; Evelina Kanova; Mangesh Bhide
Journal:  Microb Cell Fact       Date:  2017-01-23       Impact factor: 5.328

Review 6.  Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.

Authors:  Janusz Wesolowski; Vanina Alzogaray; Jan Reyelt; Mandy Unger; Karla Juarez; Mariela Urrutia; Ana Cauerhff; Welbeck Danquah; Björn Rissiek; Felix Scheuplein; Nicole Schwarz; Sahil Adriouch; Olivier Boyer; Michel Seman; Alexei Licea; David V Serreze; Fernando A Goldbaum; Friedrich Haag; Friedrich Koch-Nolte
Journal:  Med Microbiol Immunol       Date:  2009-06-16       Impact factor: 3.402

Review 7.  Properties, production, and applications of camelid single-domain antibody fragments.

Authors:  M M Harmsen; H J De Haard
Journal:  Appl Microbiol Biotechnol       Date:  2007-08-18       Impact factor: 4.813

8.  Lactobacillli expressing llama VHH fragments neutralise Lactococcus phages.

Authors:  Anna Hultberg; Denise M Tremblay; Hans de Haard; Theo Verrips; Sylvain Moineau; Lennart Hammarström; Harold Marcotte
Journal:  BMC Biotechnol       Date:  2007-09-17       Impact factor: 2.563

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.